Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure
Article
[키워드] “COVID-19
antibodies
anticoagulation
antiplatelet
approved
AstraZeneca
AZD1222
ChAdOx1 nCoV-19
clinical manifestation
coagulation disorder
concerning
Corona
Coronavirus infection
Course
COVID-19
COVID-19 vaccine
COVID-19 vaccine AstraZeneca
cranial
death
diagnosed
diagnostic
died
elevated
EMA
European Medicines Agency
evaluated
event
exposure
expression
first vaccination
headache
Headaches
immunological
Intervention
Intracerebral hemorrhage
Intracranial
Laboratory
management
Manifestations
Mild
MRI
normalized
observation
occipital
Oxford
Patient
Platelet
platelet factor 4 antibodies
Prevent
raised
resulting
rheolysis
Seizure
Sinus
somnolence
Spike protein
the vaccine
thrombocytopenia
thrombosis
thrombotic event
Treatment
university
vaccination
Vaccine
venous
Venous sinus thrombosis
venous thromboembolic
while
women
[DOI] 10.3390/jcm10081599 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm10081599 PMC 바로가기 [Article Type] Article